Bright Angel Therapeutics to leverage Schrödinger’s best-in-class drug discovery platforms to develop novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections New York, NY and Toronto, Canada – Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, and MaRS Innovation, a non-profit organization supporting the commercialization of research breakthroughs […]
Schrödinger to Receive Research Funding and Milestone Payments from ONO New York, NY － Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, today announced a research collaboration with Ono Pharmaceutical (ONO) to develop novel therapeutics. Under the terms of the agreement, the companies will work together to leverage Schrödinger’s computational […]
New York, NY － Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, announced today that it has received a payment from Sanofi for reaching a major milestone in its multi-year, multi-target drug discovery collaboration. The project in which the milestone was achieved is one of several programs that Schrödinger is […]
BUDAPEST, Hungary and TOULOUSE, France and BOSTON — ChemAxon, a leading provider of cheminformatics software for life sciences announces a strategic partnership with DEXSTR, an innovative provider of Scientific Knowledge Management solutions. Organizations have an unprecedented quantity of continuously generated unstructured data. Inquiro, DEXSTR’s Scientific Knowledge Management System significantly enhances the R&D digitalization process, turning unstructured data into actionable insight. […]
We are pleased to announce Schrödinger software release 2017-4, which is available for download now. This quarterly release includes usability improvements and performance enhancements across all of our software. Click here to learn more about new features in 2017-4.
Collaboration to Focus on Computational Chemistry and Molecular Recognition in the Human Body NEW YORK, NY and SHANGHAI, CHINA (November 7, 2017) – Schrödinger, Inc., a world-leading provider of advanced molecular simulations and drug discovery software solutions, and ShanghaiTech University in China have reached an agreement to develop a strategic partnership and establish the Shanghai […]
New Informatics Solution for Biologics Discovery Helps Multidisciplinary and Multi-Organizational Teams Capture and Track Projects Bishop’s Stortford, England – Dotmatics, a leading provider of scientific informatics solutions and services, today announced major global biologics capabilities and the addition of key personnel and workflows that allow discovery teams to capture experiments, processes, and improve decision-support based on […]
NEW YORK, NY– Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, today announced the appointment of Dov Goldstein, M.D., as Chief Financial Officer. Dr. Goldstein brings to Schrödinger over 20 years of strategic financial experience in the healthcare sector, most recently as a Managing Partner at Aisling Capital, a […]
Enhanced API offers improved functionality and ease of use Bishops Stortford, England – Dotmatics, a leading provider of scientific informatics solutions and services, today announced Version 5.2, a new release of the company’s informatics suite designed to enhance the end user experience and make scientists more productive. Key upgrades include a completely redesigned Dotmatics Chemselector application for […]
LONDON. Scottish Equity Partners (SEP) completes a significant investment in Dotmatics. The company, founded in 2005, is a leading global scientific informatics software provider delivering enterprise solutions tailored to the modern, highly collaborative and mobile scientific environments. Dotmatics provides solutions for pharmaceutical, biotechnology, academia, food and beverage, oil and gas, and agrochemical industries. The funding will enable Dotmatics to continue […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
